Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 11241 clinical trials
Immunotherapy in Lung Cancer: Treatment After IO Cessation.

Immunotherapy is now a standard of care for first-line and eventually salvage therapy in patients with stage IV NSCLC and as adjuvant after RT-CT for stage III NSCLC. The aim of the study is determining the therapeutic landscape and the reason for immunotherapy cessation.

immunomodulators
melanoma
small cell lung cancer
salvage therapy
non-melanoma skin cancer
  • 0 views
  • 05 Aug, 2020
Factors Affecting the Prognosis of Early Ovarian Cancer

To elucidate factors affecting survival of early stage ovarian cancer

ovarian cancer
ovarian cancer stage
cancer
  • 0 views
  • 05 Aug, 2020
RadioPathomics Artificial Intelligence Model to Predict nCRT Response in Locally Advanced Rectal Cancer

In this study, investigators utilize a radiopathomics integrated Artificial Intelligence (AI) supportive system to predict tumor response to neoadjuvant chemoradiotherapy (nCRT) before its administration for patients with locally advanced rectal cancer (LARC).

adjuvant chemotherapy
cancer
adenocarcinoma of rectum
adjuvant therapy
adjuvant
  • 0 views
  • 16 Feb, 2024
  • 3 locations
Early Diagnosis of Upper Digestive Tract Disease

Upper digestive tract cancer (UDC) is a major disease burden worldwide encompassing all cancers involving the digestive tract (from oral cavity to duodenum).

early detection
mass spectrometry
cavities
cancer
gastrointestinal disorder
  • 4 views
  • 05 Aug, 2020
Radiomics-based Artificial Intelligence System to Predict Neoadjuvant Treatment Response in Rectal Cancer

In this study, investigators utilize a radiomics prediction model to predict the tumor response to neoadjuvant chemoradiotherapy (nCRT) before the nCRT is administered for patients with locally advanced rectal cancer (LARC).

adjuvant chemotherapy
cancer
adenocarcinoma of rectum
adjuvant therapy
adjuvant
  • 0 views
  • 16 Feb, 2024
  • 3 locations
Early Palliative Care in Pancreatic Cancer - a Quasi-experimental Study

Patients are seen by the palliative care team on home-visits every four weeks throughout their trajectory, and quality of life is evaluated using the following quality of life questionnaires (QLQs): European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for Cancer Patients receiving palliative care (EORTC QLQ-C15-PAL), …

palliative care
advanced cancer
anxiety
depression
cancer
  • 0 views
  • 16 Feb, 2024
  • 1 location
Influence of Hormone Treatment in Radiation Therapy for Bladder Cancer

Bladder cancer is often treated with cystectomy or radiation therapy. Following radiation therapy patients will often have severe side effects from the treatment.

bladder cancer
androgen
hormone therapy
androgen suppression
endocrine therapy
  • 0 views
  • 16 Feb, 2024
  • 1 location
Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer

This is a Norwegian prospective observational study that evaluates the resectability rate in patients with borderline resectable and locally advanced pancreatic cancer who received neoadjuvant chemotherapy in a population based cohort. Eligible patients are treated with neoadjuvant chemotherapy possibly followed by surgical exploration and resection.

pancreatic cancer
folfirinox
pancreatic adenocarcinoma
adenocarcinoma
surgical exploration
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Community-Based Educational Intervention to Improve Colorectal Cancer Screening

Learning what encourages people and what keeps people from getting colorectal cancer screening may help researchers develop an educational tool for colorectal cancer screening that addresses colorectal cancer knowledge, beliefs, and cultural factors in underserved populations.

screening for colorectal cancer
colorectal cancer
cancer screening
educational intervention
carcinoma
  • 0 views
  • 05 Aug, 2020
Prospective Trial for the Evaluation of Radiogenomics in Advanced Rectal Cancer

In patients with advanced rectal cancer, molecular subtypes will be identified by preoperative biopsy, CT, MRI / PET radiomics analysis, clinical features, and clinical features will be confirmed and compared.

chemoradiotherapy
rectal cancer
cancer
  • 0 views
  • 16 Feb, 2024
  • 1 location